Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Geller

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Statistical Science : a Review Journal of the Institute of Mathematical Statistics|December 5, 2024
Robust Tests in Genome-Wide Scans under Incomplete Linkage DisequilibriumGang Zheng, Jungnam Joo, Dmitri Zaykin, et al.
Clinical Trials (London, England)|November 26, 2008
Use of biological assignment in hematopoietic stem cell transplantation clinical trialsBrent Logan, Eric Leifer, Chris Bredeson, et al.
Controlled Clinical Trials|December 4, 2003
Overview of the DIG trialJoseph F Collins, Debra Egan, Salim Yusuf, et al.
Fundamental & Clinical Pharmacology|August 12, 2010
Surrogate endpoints in randomized cardiovascular clinical trialsMichael Domanski, Stuart Pocock, Corine Bernaud, et al.
Clinical Trials (London, England)|August 24, 2007
Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trialsGarnet L Anderson, Charles Kooperberg, Nancy Geller, et al.
Controlled Clinical Trials|December 4, 2003
Lessons learned from the DIG trialDebra Egan, Nancy Geller, Salim Yusuf, et al.
Journal of Biopharmaceutical Statistics|October 31, 2003
Industry, government, and academic panel discussion on multiple comparisons in a "real" phase three clinical trialPeter Bauer, George Chi, Nancy Geller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survivalEdward Gorak, Nancy Geller, Ramaprasad Srinivasan, et al.
Blood|October 11, 2003
Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumorsCristian Carvallo, Nancy Geller, Roger Kurlander, et al.
British Journal of Haematology|March 29, 2002
A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndromeJaroslaw P Maciejewski, Antonio M Risitano, Elaine M Sloand, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Statistical Science : a Review Journal of the Institute of Mathematical Statistics|December 5, 2024
Robust Tests in Genome-Wide Scans under Incomplete Linkage DisequilibriumGang Zheng, Jungnam Joo, Dmitri Zaykin, et al.
Clinical Trials (London, England)|November 26, 2008
Use of biological assignment in hematopoietic stem cell transplantation clinical trialsBrent Logan, Eric Leifer, Chris Bredeson, et al.
Controlled Clinical Trials|December 4, 2003
Overview of the DIG trialJoseph F Collins, Debra Egan, Salim Yusuf, et al.
Fundamental & Clinical Pharmacology|August 12, 2010
Surrogate endpoints in randomized cardiovascular clinical trialsMichael Domanski, Stuart Pocock, Corine Bernaud, et al.
Clinical Trials (London, England)|August 24, 2007
Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trialsGarnet L Anderson, Charles Kooperberg, Nancy Geller, et al.
Controlled Clinical Trials|December 4, 2003
Lessons learned from the DIG trialDebra Egan, Nancy Geller, Salim Yusuf, et al.
Journal of Biopharmaceutical Statistics|October 31, 2003
Industry, government, and academic panel discussion on multiple comparisons in a "real" phase three clinical trialPeter Bauer, George Chi, Nancy Geller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survivalEdward Gorak, Nancy Geller, Ramaprasad Srinivasan, et al.
Blood|October 11, 2003
Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumorsCristian Carvallo, Nancy Geller, Roger Kurlander, et al.
British Journal of Haematology|March 29, 2002
A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndromeJaroslaw P Maciejewski, Antonio M Risitano, Elaine M Sloand, et al.
Pageof 6